Keeley J. Brookes

7.4k total citations
57 papers, 1.9k citations indexed

About

Keeley J. Brookes is a scholar working on Psychiatry and Mental health, Molecular Biology and Genetics. According to data from OpenAlex, Keeley J. Brookes has authored 57 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Psychiatry and Mental health, 21 papers in Molecular Biology and 17 papers in Genetics. Recurrent topics in Keeley J. Brookes's work include Attention Deficit Hyperactivity Disorder (21 papers), Alzheimer's disease research and treatments (12 papers) and Bipolar Disorder and Treatment (10 papers). Keeley J. Brookes is often cited by papers focused on Attention Deficit Hyperactivity Disorder (21 papers), Alzheimer's disease research and treatments (12 papers) and Bipolar Disorder and Treatment (10 papers). Keeley J. Brookes collaborates with scholars based in United Kingdom, United States and Ireland. Keeley J. Brookes's co-authors include Philip Asherson, Xiaohui Xu, Eric Taylor, Wai Chen, Jonathan Mill, Kevin Morgan, Chih‐Ken Chen, Lindsey Kent, Michael Gill and Yu‐Shu Huang and has published in prestigious journals such as Nature Communications, PLoS ONE and NeuroImage.

In The Last Decade

Keeley J. Brookes

54 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keeley J. Brookes United Kingdom 26 759 488 453 321 293 57 1.9k
Yanli Zhang‐James United States 21 606 0.8× 506 1.0× 407 0.9× 243 0.8× 248 0.8× 61 1.7k
Sergi Papiol Germany 26 857 1.1× 274 0.6× 428 0.9× 408 1.3× 344 1.2× 107 2.2k
Daimei Sasayama Japan 26 563 0.7× 402 0.8× 324 0.7× 178 0.6× 308 1.1× 119 2.1k
Síntia Belangero Brazil 27 649 0.9× 249 0.5× 486 1.1× 426 1.3× 209 0.7× 123 2.1k
Paul McBride United States 19 712 0.9× 673 1.4× 588 1.3× 249 0.8× 375 1.3× 43 2.2k
Shusuke Numata Japan 30 704 0.9× 448 0.9× 1.1k 2.3× 558 1.7× 231 0.8× 101 2.7k
W.M.A. Verhoeven Netherlands 25 497 0.7× 364 0.7× 476 1.1× 536 1.7× 258 0.9× 109 1.7k
Nicole R. Zürcher United States 29 506 0.7× 893 1.8× 403 0.9× 323 1.0× 210 0.7× 60 2.4k
Consuelo Walss‐Bass United States 29 614 0.8× 213 0.4× 886 2.0× 398 1.2× 268 0.9× 108 2.6k
Yingjun Zheng China 22 381 0.5× 319 0.7× 342 0.8× 159 0.5× 224 0.8× 79 1.6k

Countries citing papers authored by Keeley J. Brookes

Since Specialization
Citations

This map shows the geographic impact of Keeley J. Brookes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keeley J. Brookes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keeley J. Brookes more than expected).

Fields of papers citing papers by Keeley J. Brookes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keeley J. Brookes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keeley J. Brookes. The network helps show where Keeley J. Brookes may publish in the future.

Co-authorship network of co-authors of Keeley J. Brookes

This figure shows the co-authorship network connecting the top 25 collaborators of Keeley J. Brookes. A scholar is included among the top collaborators of Keeley J. Brookes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keeley J. Brookes. Keeley J. Brookes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brookes, Keeley J., et al.. (2025). Transcriptome-wide alternative splicing and transcript-level differential expression analysis of post-mortem Lewy body dementia brains. Acta Neuropsychiatrica. 37. e9–e9. 1 indexed citations
2.
Pearce, A. V., et al.. (2025). OAS1: A Protective Mechanism for Alzheimer’s Disease? An Exploration of Data and Possible Mechanisms. International Journal of Molecular Sciences. 26(2). 524–524.
3.
4.
Leonenko, Ganna, Sarah Bauermeister, Joshua Stevenson‐Hoare, et al.. (2024). Dementias Platform UK: Bringing genetics into life. Alzheimer s & Dementia. 20(5). 3281–3289. 2 indexed citations
5.
Leonenko, Ganna, Eftychia Bellou, Amanda Myers, et al.. (2024). Chromosome X-wide association study in case control studies of pathologically confirmed Alzheimer’s disease in a European population. Translational Psychiatry. 14(1). 358–358. 4 indexed citations
6.
Brookes, Keeley J., Tamar Guetta‐Baranes, Alan Thomas, & Kevin Morgan. (2023). An alternative method of SNP inclusion to develop a generalized polygenic risk score analysis across Alzheimer's disease cohorts. PubMed. 2. 1120206–1120206. 2 indexed citations
7.
Shireby, Gemma, Emma Dempster, Rebecca G. Smith, et al.. (2022). DNA methylation signatures of Alzheimer’s disease neuropathology in the cortex are primarily driven by variation in non-neuronal cell-types. Nature Communications. 13(1). 5620–5620. 60 indexed citations
8.
Graham, Andrew, Thomas M. Piers, Maryam Shoai, et al.. (2021). A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain. 144(12). 3727–3741. 75 indexed citations
9.
Shireby, Gemma, Jonathan Davies, Paul T. Francis, et al.. (2020). Recalibrating the epigenetic clock: implications for assessing biological age in the human cortex. Brain. 143(12). 3763–3775. 110 indexed citations
10.
Hannon, Eilís, Gemma Shireby, Keeley J. Brookes, et al.. (2020). Genetic risk for Alzheimer’s disease influences neuropathology via multiple biological pathways. Brain Communications. 2(2). fcaa167–fcaa167. 6 indexed citations
11.
Brookes, Keeley J., Tamar Guetta‐Baranes, Rita Guerreiro, et al.. (2020). Genetic variants in glutamate-, Aβ−, and tau-related pathways determine polygenic risk for Alzheimer's disease. Neurobiology of Aging. 101. 299.e13–299.e21. 11 indexed citations
12.
Chappell, Sally, Tulsi Patel, Tamar Guetta‐Baranes, et al.. (2018). Observations of extensive gene expression differences in the cerebellum and potential relevance to Alzheimer’s disease. BMC Research Notes. 11(1). 646–646. 17 indexed citations
13.
Barber, Imelda, Tulsi Patel, Tamar Guetta‐Baranes, et al.. (2017). Methylation Profiling RIN3 and MEF2C Identifies Epigenetic Marks Associated with Sporadic Early Onset Alzheimer’s Disease. Journal of Alzheimer s Disease Reports. 1(1). 97–108. 16 indexed citations
14.
Brookes, Keeley J., et al.. (2010). Polymorphisms of the steroid sulfatase (STS) gene are associated with attention deficit hyperactivity disorder and influence brain tissue mRNA expression. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(8). 1417–1424. 26 indexed citations
15.
Hawi, Ziarih, Lindsey Kent, Matthew Hill, et al.. (2009). ADHD and DAT1: Further evidence of paternal over‐transmission of risk alleles and haplotype. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 153B(1). 97–102. 30 indexed citations
16.
Brookes, Keeley J., Wai Chen, Xiaohui Xu, Eric Taylor, & Philip Asherson. (2006). Association of Fatty Acid Desaturase Genes with Attention-Deficit/Hyperactivity Disorder. Biological Psychiatry. 60(10). 1053–1061. 106 indexed citations
17.
Brookes, Keeley J., Xiaohui Xu, Wai Chen, et al.. (2006). The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Molecular Psychiatry. 11(10). 934–953. 6 indexed citations
18.
Brookes, Keeley J., Jonathan Mill, Camila Guindalini, et al.. (2005). A common haplotype of the dopamine transporter gene is associated with attention deficit hyperactivity disorder and interacts with prenatal exposure to alcohol. American Journal of Medical Genetics Part A. 54–54. 1 indexed citations
19.
Mill, Jonathan, et al.. (2004). Association study of serotonin transporter gene polymorphisms in attention deficit hyperactivity disorder. American Journal of Medical Genetics Part A. 115–115.
20.
Knight, Jo, Xinni Xu, Keeley J. Brookes, et al.. (2003). DNA pooling identifies association of the noradrenergic transporter gene (NET1) with attention deficit hyperactivity disorder (ADHD).. The American Journal of Human Genetics. 73(5). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanli Zhang‐James Breakdown of academic impact, for papers by Sergi Papiol Breakdown of academic impact, for papers by Daimei Sasayama Breakdown of academic impact, for papers by Síntia Belangero Breakdown of academic impact, for papers by Paul McBride Breakdown of academic impact, for papers by Shusuke Numata Breakdown of academic impact, for papers by W.M.A. Verhoeven Breakdown of academic impact, for papers by Nicole R. Zürcher Breakdown of academic impact, for papers by Consuelo Walss‐Bass Breakdown of academic impact, for papers by Yingjun Zheng
Rankless by CCL
2026